Summary
The proliferation of three mammary carcinoma cell lines was explored for the effectiveness of dihydrotestosterone (DHT) and the antiandrogenic substances cyproterone acetate (CPA) or hydroxyflutamide. The cell growth, determined in multiple experimental cultures of the estrogen-sensitive lines MCF-7 and EFM-19, was stimulated by 10-9 M to 10-6 M DHT, whereas estrogen-resistant MFM-21 cells were unresponsive to the hormonal factors applied. Growth-promoting effects of 10-8 M to 10-6 M CPA were detected in cultures of those cell lines which were sensitive to estrogen and androgen. Competition experiments with DHT and the antiandrogens suggested involvement of the androgen receptor in the stimulation of cell growth by CPA. Participation of the estrogen receptor was excluded by lack of competition between CPA and the enhancement of proliferation by estradiol-17β. At the receptor level the anti-androgens were able to compete with androgen binding. The results of the study demonstrate androgenic properties of CPA in regard to the growth of human mammary carcinoma cells.
Similar content being viewed by others
References
Allegra JC, Lippman ME, Thompson EG, Simon R, Green L, Barlock A, Huff KK, Aitkin S, Do HMT, Warren R (1979) Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen and glucocorticoid receptors in human breast cancer. Cancer Res 39:1447–1454
Blossey HC, Bartsch HH, Köbberling J (1982) Die mögliche klinische Bedeutung des Androgenrezeptors in Mammakarzinomen. In: Jonat W, Maass H (Hrsg) Steroidhormonrezeptoren im Karzinomgewebe Enke, Stuttgart, S. 164–170
Bryan RM, Mercer RJ, Benett RC, Rennie GC, Lie TH, Morgan FJ (1984) Androgen receptors in breast cancer. cancer 54:2436–2440
Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM (1986) Relation of in vitro properties to tumorgenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res 46:6339–6348
CCNSC Breast Cancer Group (1964) Testosterone propionate therapy in breast cancer. J Am Med Assoc 188:1069–1070
Cole MP, Jones CTA, Todd IDH (1971) A new antiestrogenic agent in late breast cancer. Br J Cancer 25:270–275
Darbre P, Yates J, Curtis S, King RJB (1983) Effect of estradiol on human breast cancer cells in vitro. Cancer Res 43:349–354
Dawood MY, Saxena BB (1976) Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles. Am J Obstet Gynecol 126:430–435
Dixon M, Webb C (1971) Enzymes, 2nd edn. Longman, London
Hackenberg R, Schulz K-D, Schmidt-Rhode P, Hölzel F, Sturm G, Würz H, Reusch K (1986) Antiandrogens in breast cancer. Rev Endocrine Rel Cancer, suppl 18(63):57–60
Hofmann J, Sernetz M (1983) A kinetic study on the enzymatic hydrolysis of fluoresceindiacetate and fluorescein-di-β-D-galactopyranoside. Anal Biochem 131:180–185
Hölzel F, Albrecht M, Simon WE, Hänsel M, Metz R, Schweizer J, Dietel M (1985) Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture. J Cancer Res Clin Oncol 109:217–226
Hölzel F, Simon WE, Albrecht M (1986) Untersuchungen an Zellkulturen von Mammakarzinomen. Einfluß von Proteo- und Steroidnormonen auf DNA-Synthese und Zellwachstum. In: Bellmann O, Krebs D, Totović V (Hrsg) Hormonabhängigkeit des mammakarzinoms. Aktuelle diagnostische Möglichkeiten. Zuckschwerdt, München, S. 122–135 (Aktuelle Onkologie, vol 31)
Horwitz KB, Costlow ME, McGuire WL (1975) MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids 26:785–795
Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 253:2223–2228
Kunzmann R, Hölzel F (1987) Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage. Cancer Genet Cytogenet 28:201–212
Liao S, Howell DK, Chang T-M (1974) Action of a nonsteroidal antiandrogen, flutamide, on the receptor binding and nuclear retention of 5α-dihydrotestosterone in rat ventral prostate. Endocirnology 94:1205–1209
Lippman ME, Bolan G, Huff K (1975) Human breast cancer responsive to androgens in long-term tissue culture. Nature 258:339–341
Lippman ME, Bolan G, Huff K (1976a) The effect of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4599–4601
Lippman ME, Bolan G, Huff K (1976b) The effect of androgens and antiandrogens on hormone-responsive breast cancer in long-term tissue culture. Cancer Res 36:4610–4618
Longcope C, Pratt JH, Schneider SH, Fineberg SE (1978) Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab 46:146–152
MacDonald PC, Rombaut RP, Siiteri PK (1967) Plasma precursors of estrogen. I. Extent of conversion of plasma α-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. J Clin Endocrinol 27:1103–1111
McIndoe JH, Etre LA (1981) An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 53:836–842
Miller MA, Lippman WE, Katzenellenbogen BS (1984) Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Cancer Res 44:5038–5045
Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM (1985a) Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313:231–233
Miller WR, Telford J, Dixon JM, Hawkins RA (1985b) Androgen receptor activity in human breast cancer and its relationship with oestrogen and progesterone receptor activity. Br J Cancer Clin Oncol 21:539–542
Mowszowicz I, Bieber DE, Chung KW, Bullock LP, Bardin CW (1974) Synandrogenic and antiandrogenic effect of progestins: Comparison with nonprogestational antiandrogens. Endocrinology 95:1589–1599
Nawata H, Bronzert D, Lippman ME (1981a) Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 256:5016–5021
Nawata H, Chong MJ, Bronzert D, Lippman ME (1981b) Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture. J Biol Chem 256:6895–6902
Neri R, Kassem N (1984) Biological and clinical properties of anti-androgens. Prog Cancer Res Ther 31:507–518
Neumann F, Steinbeck H (1974) Antiandrogens. In: Eichler O, Herken M, Faruh H, Welch AD (Hrsg) Handbuch der experimentellen Pharmakologie, vol XXXV/2. Springer, Berlin Heidelberg New York, S. 235–484
Osborne CK, Hobbs K, Clark GM (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45:584–590
Peets EA, Henson MF, Neri R (1974) On the mechanism of the anti-androgenic actionof flutamide (a-a-a-trifluoro-2-methyl-4′-nitro-m-propionotoluidide) in the rat. Endocrinology 94:532–540
Reddel RR, Murphy LC, Hall RE, Sutherland RL (1985) Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 45:1525–1531
Santen RJ (1986) Aromatase inhibitors for treatment of breast cancer: Current concepts and new perspectives. Breast Cancer Res Treat 7 [Suppl]:23–36
Schulz K-D, Kremer S, Würz H, Reusch K (1982) Cyproterone acetate in metastasizing breast cancer. Preliminary results. Verh Dtsch Krebsges 3:187
Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman WE (1983) Cronal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 43:2223–2239
Shafie SM, Grantham FH (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67:51–56
Shapiro E, Lippman M (1985) Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion. J Steroid Biochem 22:15–20
Siiteri PK, MacDonald PC (1973) Role of extraglandular estrogen in human endocrinology. In: Geiger SR (ed) Handbook of Physiology, sect 7, vol II,1. Williams and Wilkins, Baltimore, pp 615–629
Simon WE, Albrecht M, Trams G, Dietel M, Hölzel F (1984a) In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen and prolactin. J Natl Cancer Inst 73:313–321
Simon WE, Hänsel M, Dietel M, Matthiesen L, Albrecht M, Hölzel F (1984b) Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells. In Vitro 20:157–166
Soule HD, Vasquez J, Long A, Albert S, Brennan MJ (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1413
Soule HD, McGrath CM (1980) Estrogen-responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10:177–189
Stover EP, Krishnan AV, Feldman D (1987) Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7). Endocrinology 120:2597–2603
Thomas DB (1986) Hormones and hormone receptors in the etiology of breast cancer. Breast Cancer Res Treat 7 [Suppl]:11–22
Trams G, Maass H (1977) Specific binding of estradiol and dihydrotestosterone in human mammary cancers. Cancer Res 37:258–261
Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H (1984) Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF-7 cells. Cancer Res 44:2084–2088
Vorherr H, Messer RH (1978) Breast cancer: potentially predisposing and protecting factors. Role of pregnancy, lactation and endocrine status. Am J Obstet Gynecol 130:335–358
Wagner RK, Jungblut PW (1976) Oestradiol and dihydrotestosterone receptors in normal and neoplastic human mammary tissue. Acta Endocrinol 82:105–120
Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman M (1983) Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. J Natl Cancer Inst 71:687–695
Wilding G, Chen M, Gelman EP (1987) LHRH agonists and human breast cancer cells. Nature 329:770
Würz H, Schulz K-D, Citoler P, Kaiser R (1982) Verteilung von Östrogen-, Gestagen-, Androgen- und Kortikosteroidrezeptoren in Mammakarzinomen. In: Jonat W, Maass H (Hrsg) Steroidhormonrezeptoren im Karzinomgewebe. Enke, Stuttgart, pp 23–30
Zava DT, McGuire WL (1978) Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology 103:624–631
Author information
Authors and Affiliations
Additional information
On the occasion of the 60th anniversary of Prof. Dr. H. Maass, Universitäts-Frauenklinik Hamburg
Supported by the Deutsche Forschungsgemeinschaft, SFB 215 (Tumor und Endokrinium) and Kempkes-Stiftung, Marburg
Rights and permissions
About this article
Cite this article
Hackenberg, R., Hofmann, J., Hölzel, F. et al. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol 114, 593–601 (1988). https://doi.org/10.1007/BF00398183
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00398183